The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models

Area of Science:

• Oncology
• Immunology
• Gastroenterology

Background:

• Inflammatory responses are increasingly recognized as critical drivers of cancer development.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are linked to reduced colon cancer risk, suggesting a role for their targets in tumorigenesis.
• Cyclooxygenase-2 (COX-2) and its product prostaglandin E2 (PGE2) are implicated in gastrointestinal tumor progression.

Purpose of the Study:

• To review mouse genetic studies elucidating the molecular mechanisms of inflammatory networks in gastrointestinal tumors.
• To discuss the role of specific pathways, including Toll-like receptor (TLR)/MyD88 and COX-2/PGE2, in tumor development.
• To explore the contribution of immune cells like macrophages, mast cells, and regulatory T cells to tumor promotion.

Main Methods:

• Utilized genetically engineered and chemically induced mouse tumor models mimicking sporadic and inflammation-associated tumorigenesis.
• Focused on analyzing molecular mechanisms through genetic studies in these mouse models.
• Reviewed existing literature on inflammatory pathways and immune cell involvement in gastrointestinal cancer.

Main Results:

• Demonstrated that bacterial infection can activate the TLR/MyD88 pathway, inducing COX-2 in stromal cells like macrophages.
• Highlighted the importance of the COX-2/PGE2 pathway in establishing a pro-tumorigenic inflammatory microenvironment.
• Showed that cytokines like TNF-α and IL-6 activate NF-κB and Stat3, promoting tumor development via inflammatory networks.

Conclusions:

• The inflammatory network, involving pathways like TLR/MyD88 and COX-2/PGE2, is crucial for gastrointestinal tumor development and maintenance.
• Immune cells, particularly macrophages, play a significant role in orchestrating this pro-tumorigenic inflammatory microenvironment.
• Understanding these molecular mechanisms in mouse models provides insights into therapeutic strategies for gastrointestinal cancers.